Telemedicine in the Management of Patients with Diabetes Mellitus Results of an 18-Month Follow-Up

Abstract

Introduction: Increasing number of patients with type 2 diabetes mellitus places growing demands on patient management. Addressing this issue requires the integration of innovative technologies, including telemedicine. Parameters can be measured in a home environment (self-monitoring of blood glucose, blood pressure, ecg, weight, oximetry, spirometry) by the patients themselves, with the data transmitted via suitable technology.

Methodology: Prospective, Non-Interventional, Clinical Study Conducted Under Routine Clinical Practice Conditions In a Diabetology Outpatient Clinic.

Results: A total of 216 patients were included in the telemedicine follow-up: 109 women (51.66%) and 102 men (48.34%). The average usage duration of the telemedicine kit was 8.8 months. Postprandial blood glucose levels showed the greatest improvement after six months of intervention; over time, glucose levels slightly increased but remained below baseline values. HbA1c levels (baseline 7.83% DCCT) improved initially (6.85% DCCT) and remained in the optimal range for 18 months. Among telemedicine kit users, 42.5% achieved HbA1c < 7% DCCT, while 23.3% had HbA1c > 9% DCCT, Women experienced greater weight reduction (from 85.30 kg to 84.0 kg, -1.53%) compared to men (from 98.26 kg to 97.46 kg, -0.83%). Blood pressure was the most frequently monitored parameter, with most patients maintaining values within the optimal range.

Conclusion: The transmission of data allows physicians to actively adjust treatment and recommendations without the immediate need for in-person visits, thereby reducing the time required for making relevant medical decisions and implementing them for patients.